companies: 6,640     total market cap: $100.7 T
Lumos Pharma, Inc.
LUMO

$37.45 M
Marketcap
$4.33
Share price
US
Country
$0.01
Change (1 day)
$4.58
Year High
$1.37
Year Low
Biotechnology
Categories

Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare endocrine disorders. The company is headquartered in Austin, Texas.

marketcap

Stock price history for Lumos Pharma, Inc. (LUMO)

Highest end of day price: $56.87 USD on 2015-04-13

Lowest end of day price: $0.89 USD on 2020-03-18

Stock price history of Lumos Pharma, Inc. from 2011 to 2024


What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company. In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

Stock prices are delayed, the delay can range from a few minutes to several hours. MarketCap.tools is not a Financial institution.

Contact

For inquiries or if you want to report a problem write to web@marketcap.tools

© 2023 Marketcap.tools